Drug intelligence / Profile preview

roemerine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Roemerine is a natural aporphine alkaloid primarily isolated from the leaves of *Nelumbo nucifera* (Sacred Lotus) and other plants. It is extensively researched for its potent antineoplastic and antimicrobial properties. In the context of oncology, roemerine has demonstrated significant anti-prostate cancer effects by inhibiting cell proliferation and inducing apoptosis in various cell lines, including DU145, LNCaP, and PC-3, as well as reducing tumor growth in mouse models. Its mechanism of action involves the inhibition of the PI3K/Akt signaling pathway and potential DNA intercalation. Additionally, roemerine acts as an antimicrobial agent by functioning as an efflux pump inhibitor, which can help reverse multidrug resistance in pathogens such as *Staphylococcus aureus*.

Other names
(-)-roemerineroemerin1,2-methylenedioxy-6-methylaporphine
02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR2B (5-Hydroxytryptamine Receptor 2B)HTR2C (5-hydroxytryptamine 2C receptor)ADRA1A (α1A)DNAPI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on roemerine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on roemerine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call